In each group, the IC50 values for cisplatin showed that knockdown of ZBTB11 increased the cisplatin sensitivity of BC cells, whereas rescue of the expression of DDX1 blocked this effect (Figure 7A). Here, ZBTB11 is linked to breast cancer.